Close

FibroGen (FGEN) PT Lowered to $38 at Goldman Sachs

March 30, 2020 4:24 AM EDT
Get Alerts FGEN Hot Sheet
Price: $1.07 --0%

Rating Summary:
    3 Buy, 9 Hold, 2 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 11 | Down: 8 | New: 13
Join SI Premium – FREE
Goldman Sachs analyst Paul Choi lowered the price target on FibroGen (NASDAQ: FGEN) to $38.00 (from $46.00) while maintaining a Neutral rating.

You May Also Be Interested In





Related Categories

Analyst PT Change